Clinical Trial Update: Rivaroxaban Acute Stroke Safety Study

View source ↗

Summary

A completed clinical trial evaluating the safety of rivaroxaban in patients with acute ischemic stroke or transient ischemic attack.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: University of Alberta | Conditions: Acute Ischemic Stroke, Transient Ischemic Attack | Status: COMPLETED